Skip to main content
Caplight Logo









Rheos Medicines

Rheos Medicines

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://rheosrx.com

Company Overview

Rheos Medicines was a biopharmaceutical company that developed precision medicines for autoimmune and inflammatory diseases by targeting the metabolic pathways of immune cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

precision medicinedrug discoverymetabolomicsimmunologysmall moleculebiotechautoimmune diseasemetabolic pathwaysbiomarker discoverycomputational biologyai drug discoveryin silico drug discoverymulti-omicstherapeutic targetsimmune homeostasis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rheos Medicines Comparables

Compare Rheos Medicines with similar companies based on industry and business-model similarity.

Rheos Medicines comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sitryx
84%
META Pharmaceuticals Inc.
82%
Immunai
78%

Rheos Medicines Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Rheos Medicines Filings

Explore SEC and related filing metadata, where available.

Rheos Medicines filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rheos Medicines's valuation, stock price, and market status.

Is Rheos Medicines a public or private company?

Rheos Medicines is a private company.

What is the current stock price of Rheos Medicines?

Rheos Medicines is a private company with no public stock price. No recent secondary market data is available.

How much is Rheos Medicines worth (valuation)?

Valuation information for Rheos Medicines is not publicly available.

Can I buy Rheos Medicines stock?

Rheos Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rheos Medicines's last funding round?

Funding round information for Rheos Medicines is not publicly available.

Who are the main investors in Rheos Medicines?

Investor information for Rheos Medicines is not publicly disclosed.

Will Rheos Medicines IPO soon?

No public IPO plans have been announced for Rheos Medicines.

How can I track Rheos Medicines secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rheos Medicines's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?